- Home
- ATXS vs NETD Comparison
ATXS vs NETD Comparison
Compare ATXS & NETD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- NETD
- Stock Information
- Founded
- ATXS 2008
- NETD 2023
- Country
- ATXS United States
- NETD United States
- Employees
- ATXS N/A
- NETD N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- NETD
- Sector
- ATXS Health Care
- NETD
- Exchange
- ATXS Nasdaq
- NETD Nasdaq
- Market Cap
- ATXS 401.2M
- NETD 417.9M
- IPO Year
- ATXS 2015
- NETD 2023
- Fundamental
- Price
- ATXS $4.48
- NETD $11.02
- Analyst Decision
- ATXS Strong Buy
- NETD
- Analyst Count
- ATXS 6
- NETD 0
- Target Price
- ATXS $30.00
- NETD N/A
- AVG Volume (30 Days)
- ATXS 501.6K
- NETD 153.5K
- Earning Date
- ATXS 05-20-2025
- NETD 01-01-0001
- Dividend Yield
- ATXS N/A
- NETD N/A
- EPS Growth
- ATXS N/A
- NETD N/A
- EPS
- ATXS N/A
- NETD 0.45
- Revenue
- ATXS N/A
- NETD N/A
- Revenue This Year
- ATXS N/A
- NETD N/A
- Revenue Next Year
- ATXS N/A
- NETD N/A
- P/E Ratio
- ATXS N/A
- NETD $24.43
- Revenue Growth
- ATXS N/A
- NETD N/A
- 52 Week Low
- ATXS $3.56
- NETD $10.50
- 52 Week High
- ATXS $12.92
- NETD $11.10
- Technical
- Relative Strength Index (RSI)
- ATXS 38.86
- NETD 60.54
- Support Level
- ATXS $4.25
- NETD $11.00
- Resistance Level
- ATXS $5.47
- NETD $11.03
- Average True Range (ATR)
- ATXS 0.35
- NETD 0.04
- MACD
- ATXS 0.01
- NETD 0.00
- Stochastic Oscillator
- ATXS 27.45
- NETD 38.46
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About NETD Nabors Energy Transition Corp. II
Nabors Energy Transition Corp II is a blank check company.